Sept 23 (Reuters) – UK's MHRA: * UK'S MHRA: APPROVES LURBINECTEDIN FOR ADULTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Sept 23 (Reuters) - Meta's Muse, the first major consumer product to emerge under Alexandr…
By Michelle Nichols, John Irish and Courtney Rozen UNITED NATIONS, Sept 23 (Reuters) - Executives…
HOUSTON, Sept 23 (Reuters) - US ultra low-sulfur diesel futures fell more than 5% after…
By Fergal Smith TORONTO, Sept 23 (Reuters) - The Canadian dollar weakened to an eight-week…
By Andrea Shalal WASHINGTON, Sept 23 (Reuters) - The United States is open to extending…
VIDEO SHOWS: FIFA UNDER-20 WOMEN'S WORLD CUP SEMI-FINAL HIGHLIGHTS WITH SPAIN BEATING ITALY 2-0 RESENDING…